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1. Introduction
The quality of drinking water in the United States (U.S.) is extensively monitored and regulated
by federal, state and local agencies, yet there is increasing public concern and confusion about
the safety and quality of drinking water –– both from public water systems and from bottled
water products. In the U.S., tap water and bottled water are regulated by two different agencies:
the Environmental Protection Agency (EPA) regulates public water system water (tap water)
and the Food and Drug Administration (FDA) regulates bottled water. Federal law requires
that the FDA’s regulations for bottled water must be at least as protective of public health as
EPA standards for tap water [1].
The quantity of publically supplied water which is directly consumed as drinking water is
estimated by the American Water Works Association to be less than four tenths of one percent
(<0.4%) of the total produced [2]. As a food product, however, 100% of bottled water is intended
for human consumption.
With respect to public water supplies, researchers estimate that more than 500 boil alerts
occurred in the United States in 2010 [3]. In addition, the Centers for Disease Control and
Prevention (CDC) reports that waterborne diseases, such as Cryptosporidiosis and Giardiasis,
cost the U.S. healthcare system as much as $539 million a year in hospital expenses [4]. In 2006,
EPA researchers reported an estimated 16.4 million cases of acute gastrointestinal illness per
year are caused by tap water [5]. Subsequent research has estimated that the number of illnesses
to be closer to 19.5 million cases per year [6].
In contrast, a survey of state bottled water regulatory authorities, dated June, 2009 and
conducted by the Government Accountability Office (GAO), found there were zero outbreaks
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of foodborne illness from bottled water over a 5-year period. Moreover, in testimony before a
July 9, 2009 Congressional hearing, a FDA official stated that the agency was aware of no major
outbreaks of illness or serious safety concerns associated with bottled water in the past decade
[7]. In addition, a review of the FDA’s recall database reveals that only two Class I recalls of
bottled water products have occurred since 1990. The first, occurring in Puerto Rico in June,
1990, was a recall of isopropyl alcohol that was labeled as “distilled water.” The second recall,
in 2007, involved five Armenian mineral water products imported into the U.S. with excessive
arsenic levels, as discovered by testing completed by the FDA.
Drinking water experts have begun turning their attention to the distribution systems that
carry the EPA-regulated public system drinking water from treatment plants to consumers.
Emerging research has found that microbial issues in distribution systems are causing
significant waterborne illness outbreaks, and that the outbreak incidence has been steadily
increasing since the late 1980s [8].
The purpose of this review and position paper is to help educate the public about the impor‐
tance of access to safe drinking water and inform policy makers and the general public about
issues such as water distribution systems, infrastructure repair, safe water availability, and the
EPA’s regulation of public water systems for microbial contaminants and how this compares
with the FDA’s regulation of bottled water. All of these topics combined are potentially major
contributing factors to impending health concerns and risks related to drinking water in the
United States.
2. Comparison of regulations, standards, monitoring and advisories
2.1. Regulations
Public drinking water and bottled water are both regulated extensively. These regulations
include an array of international, federal, state, and local agencies, and in some cases, trade
associations. There are health-based standards for both tap and bottled waters, and these
standards are, with few exceptions, the same [9].
Unlike tap water compliance failures, which generally result in monetary fines and require‐
ments for corrective action, under the Park Doctrine, the failure of a bottled water product to
meet the FDA Standards of Quality can result in criminal liability for the responsible person(s)
in the manufacture and distribution of a food product that causes adverse health consequences
to the public [10].
2.2. Standards
There are notable differences in standards for microbiological contaminants between bottled
water and tap water. With the promulgation of the FDA’s “Bottled Water Microbial Rule,”
effective December 1, 2009, bottled water now has standards specifically regulating total
coliform (TC) and Escherichia coli (E. coli) in both non-Public Water System (PWS) source
water and all finished product water. There are specific requirements for follow-up monitoring
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in the event of a positive test result for total coliform, i.e., each positive TC result must be
evaluated for presence of E. coli. The FDA Rule also makes clear that:
1. If E. coli is detected and confirmed in non-PWS source water, that source water is not of
a safe and sanitary quality for bottling, and must not be used as a source for bottled water.
If that water is used for bottling, the finished product is considered by the FDA to be
adulterated.
2. If E. coli is detected and confirmed in finished product water at any level, that product is
also deemed adulterated under provisions of the Federal Food, Drug, and Cosmetic Act
(FFDCA).
The EPA currently has no enforceable standard for either total coliform or E. coli in source
waters. Under the EPA Groundwater Rule (GWR), groundwater-sourced PWSs must engage
in additional source water testing and implement a sanitary survey, specified levels of
treatment, and other corrective actions, but the source is not removed from service. However,
the U.S. EPA published the revised Total Coliform Rule (rTCR) as a final rule on February 13,
2013. Although not yet promulgated, the Rule will affirm a new standard for E. coli in public
drinking water, and will also require an investigation and corrective action at groundwater
sources that test positive for E. coli. The revised TCR removes the standard for total coliform,
while the FDA continues to regulate bottled water for both total coliform and E. coli.
With regard to response when a microbial standard is exceeded, bottled water compliance is
determined from each individual test result in both the source and the finished product. When
one sample exceeds the standard of quality for E. coli, and the bottler continues to use the
source for bottling, the finished product is considered by the FDA to be adulterated and subject
to recall. The FDA also clearly stated its policy on adulterated finished product in the 2009
Bottled Water Microbial Rule.
“If E. coli is present in bottled water, then the bottled water is deemed to be adulterated under
section 402(a)(3) of the act (§ 165.110(b)(2)(i)(B); § 165.110(d)).” 74 Fed. Reg. 25651 (May 29,
2009)
Public water systems are currently required to collect a specified number of samples per
month, as is discussed in the monitoring section. The current EPA TCR maximum contaminant
level (MCL) for total coliform is “no more than 5% of monthly samples are valid for total
coliform.” For example, if a small groundwater-sourced community water system collects only
the required minimum of 25 samples per month, one of those samples may test positive for
total coliform, but the system would be in compliance with the TCR. The TCR requires positive
test results for total coliform to be confirmed for presence of E. coli. If any of the coliform
samples are positive for E. coli, a public notification, usually with a boil water order, is issued
to consumers. The new USEPA revised Total Coliform Rule will require public notification
only for E. coli when it becomes effective (date to be determined).
The comparison of microbiological standards for bottled water and tap water is presented in
the table.
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Microbiological Contaminants FDA SOQ EPA MCL
Total coliform
If positive for total coliform, follow-up
testing required to determine presence
of E. coli in source water.
No MCL in source water.
Finished product:
No MCL in finished water.
MPN: <2.2 organisms per 100 ml. (8)
MF: <4 CFU per 100 ml; arithmetic mean
shall not exceed 1 coliform organism per
100 ml. (8)
Escherichia coli (E. coli)
None detected in source water.
No MCL in source water. [11]If detected, source water not of a safe,
sanitary quality.
None detected in finished product. None detected in finished water. None
detected in any of the follow-up
samples if initial sample is positive.
If detected, product is deemed
adulterated.
Table 1. Comparison of microbiological standards
In addition, the EPA has established a guideline for heterotrophic plate count (HPC) bacteria
of 500 CFU/ml as a means of demonstrating adequate levels of disinfection in the distribution
system. This is not a health-based standard, and it is only used to indicate adequate disinfection
in the distribution system. There are no standards or guidelines for HPC in bottled water.
However, in 2002, the World Health Organization published a report on HPC bacteria in
drinking water, concluding that “The available body of evidence supports the conclusion that,
in the absence of fecal contamination, there is no direct relationship between HPC values in
ingested water and human health effects in the population at large.” Therefore, the HPC
bacteria found in natural bottled waters is considered to be part of the natural flora of the water,
and does not pose a health risk in the absence of fecal indicators such as E. coli [12]. Although
HPC is not an FDA-required test for bottled water, most bottled water companies currently,
or will, under upcoming rules from the Food Safety Modernization Act (FSMA), monitor for
HPC as part of their ongoing internal sanitation control and environmental monitoring
programs.
In addition, as Messner, et.al. (2006) notes, pathogens have a wide range of resistance to
public water system disinfection and Cryptosporidium is the most resistant. “Free chlorine,
the most commonly used disinfectant,  achieves virtually no inactivation of Cryptosporidi‐
um but appears very effective for inactivating most viruses [5].” The FDA permits only the
use of ground water not under the direct influence of surface water, as defined in 21 C.F.R.
§141.2,  as  source water for bottling.  Exclusion of  such source waters also precluded the
need to regulate bottled water for surface water parasites like Cryptosporidium parvum and
Giardia lamblia.
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2.3. Monitoring
It is in the area of monitoring activities that tap water and bottled water truly diverge. One
major reason for this divergence is the method of delivery. Tap water is delivered to consumers
through systems of underground piping, while bottled water is packaged in a sealed container
and delivered to consumers through retail outlets and home delivery.
2.4. EPA monitoring requirements — Microbiological testing frequencies
Testing frequency for total coliform at groundwater and surface water-sourced Community
Water Systems (CWSs) is based primarily on the population served. The number of samples
required is prescribed on a monthly schedule. Therefore, a CWS will collect a minimum of
anywhere from 1 up to 480 samples per month. The following table, which lists the number of
samples to be tested, is taken from 40 CFR 141:
CWS Monitoring schedule for total coliform (From the USEPA RTCR) [11]
Population served
Minimum number of samples per month
2,501 to 3,300 3
3,301 to 4,100 4
4,101 to 4,900 5
4,901 to 5,800 6
5,801 to 6,700 7
6,701 to 7,600 8
7,601 to 8,500 9
8,501 to 12,900 10
12,901 to 17,200 15
17,201 to 21,500 20
21,501 to 25,000 25
25,001 to 33,000 30
33,001 to 41,000 40
41,001 to 50,000 50
50,001 to 59,000 60
59,001 to 70,000 70
70,001 to 83,000 80
83,001 to 96,000 90
96,001 to 130,000 100
130,001 to 220,000 120
220,001 to 320,000 150
320,001 to 450,000 180
450,001 to 600,000 210
600,001 to 780,000 240
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Population served
780,001 to 970,000 270
970,001 to 1,230,000 300
1,230,001 to 1,520,000 330
1,520,001 to 1,850,000 360
1,850,001 to 2,270,000 390
2,270,001 to 3,020,000 420
3,020,001 to 3,960,000 450
3,960,001 or more 480
2.5. FDA monitoring requirements
Bottled water sources (other than municipal water sources) are required to be tested for total
coliform weekly at each source used for bottling. If any source water sample is positive for
total coliform, the FDA requires that it be evaluated for presence of E. coli. If a sample is
confirmed to be contaminated with E. coli, the source is considered not suitable for bottling,
and any product that contains water from that source is considered by the FDA to be adulter‐
ated.
Each bottled water finished product type (spring water, purified water, fluoridated water, etc.)
is required to be tested for total coliform weekly. If any product sample is positive for total
coliform, the FDA requires that it be evaluated for presence of E. coli. If a sample is confirmed
to be contaminated with E. coli, the product type is considered by the FDA to be adulterated.
To fully understand a comparison of bottled water testing and public water system testing,
one must look at the relative size of the operations and the amount of water processed by each.
The FDA states in the preamble to their March 3, 2003 direct final rule for radionuclides that
they base sample frequency on the following:
“According to EPA’s per capita total water use estimates applied to bottled water, an average
bottled water facility processes as much water as a municipal system serving between 42 and
72 households… serving between 100 and 500 people, which is the closest category EPA
presents.”
Applying this principle, a community water system serving between 100 and 500 people is
required by the USEPA to test a minimum of one (1) total coliform sample per month. The
FDA requires one (1) total coliform sample per week.
2.6. Comparisons of bottled water plant testing and PWS testing for total coliform
For more direct comparison of bottled water and public water testing, here are examples of
each for total coliform.
In the table below, a large bottled water plant packaging approximately 250,000 gallons per
day is compared to New York City, which, according to 2009 data, distributed approximately
1.086 billion gallons of water per day within its distribution system.
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Bottled Water Plant (large bottler, 1) (product type) New York City (large city)
250,000 gallons per day 1.086 billion gallons per day
7.5 million gallons per month 32.58 billion gallons per month
1 sample per week; 4 samples per month 480 samples per month (~16 samples per day)
1 sample per 1,875,000 gallons 1 sample per 67,875,000 gallons
Sample Ratio: 36:1
Disclaimer: Both the bottled water plant and New York City likely test more than the minimum number of samples
each month. Numbers above based on minimum regulatory requirements.
Table 2. Total coliform testing comparison – Large City
As the table above shows, even though New York City is required to collect a minimum of 480
samples per month, when those samples are viewed on a gallons of water produced basis, the
bottled water plant tests 36 times more frequently than the New York City system. Of course,
this assumes only the minimum number of samples required by the FDA and the EPA is
collected. In all likelihood, both the bottled water plant and New York City are collecting more
than the minimum number of samples.
Below is a comparison of large bottled water plant with a smaller public water system – the
groundwater-based CWS serving 10,000 that was reviewed earlier in this paper:
Bottled Water Plant (large bottler, 1) product type) CWS Serving 10,000 (small city)
250,000 gallons per day 1.2 million gallons per day
7.5 million gallons per month 36 million gallons per month
1 sample per week; 4 samples per month 10 samples per month
1 sample per 1,875,000 gallons 1 sample per 3,600,000 gallons
Sample Ratio: 2:1
Table 3. Total coliform testing comparison – Small City
The Table below compares a small home and office delivery (HOD) bottled water plant with
the CWS serving 10,000 people.
Bottled Water Plant (small bottler, 1) product type) CWS Serving 10,000 (small city)
25,000 gallons per day 1.2 million gallons per day
750,000 gallons per month 36 million gallons per month
1 sample per week, 4 samples per month 10 samples per month
1 sample per 187,500 gallons 1 sample per 3,600,000 gallons
Sample Ratio: 19:1
Table 4. Total coliform testing comparison – Small City, small Bottler
Microbial Health Risks of Regulated Drinking Waters in the United States — A Comparative Microbial Safety …
http://dx.doi.org/10.5772/58879
115
The ratio of bottled water samples tested versus the number of CWS samples tested is up to
19:1. Once again, this assumes both the bottled water plant and the community water system
are collecting only the minimum number of samples required by their respective regulations.
3. Advisories
3.1. When public drinking water does not meet EPA standards — Advisories
Public water systems must notify the public when they violate EPA or state drinking water
regulations (including monitoring requirements) in cases when the drinking water may pose
a risk to consumer’s health [13]. Under the EPA notification rule, there are three tiers of
notification, depending on the seriousness of the violation. The table below shows how public
system drinking water violations are assessed.
Required Distribution Time Notification Delivery Method
Immediate
Notice
(Tier 1)
Any time a situation occurs where there is the
potential for human health to be immediately
impacted, water suppliers have 24 hours to notify
people who may drink the water of the situation.
Water suppliers must use media outlets such as
television, radio, and newspapers, post their notice
in public places, or personally deliver a notice to
their customers in these situations.
Notice as
soon as
possible
(Tier 2)
Any time a water system provides water with
levels of a contaminant that exceed EPA or state
standards or that hasn't been treated properly, but
that doesn't pose an immediate risk to human
health, the water system must notify its customers
as soon as possible, but within 30 days of the
violation.
Notice may be provided via the media, posting, or
through the mail.
Annual
Notice
(Tier 3)
When water systems violate a drinking water
standard that does not have a direct impact on
human health (For Example, failing to take a
required sample on time) the water supplier has
up to a year to provide a notice of this situation to
its customers.
The extra time gives water suppliers the
opportunity to consolidate these notices and send
them with Annual Water Quality Reports
(Consumer Confidence Reports).
Source: EPA, “Water: Public Notification Rule”
Table 5. EPA’S 3 tiers of public notification
The EPA reports that in 2011, 93.2 percent of US public water systems met health-based
standards for drinking water. Also in that year, the EPA reports US public water systems had
8,431 total coliform rule violations affecting 9,837,344 people [14].
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3.2. When bottled water does not meet FDA standards — Advisories
Under FDA rule (21 C.F.R.§165.110), bottled water that “contains a substance at a level
considered injurious to health under section 402(a)(1) of the Federal Food, Drug, and Cosmetic
Act (the act), or that consists in whole or in part of any filthy, putrid or decomposed substance,
or that is otherwise unfit for food under section 402(a)(3) of the act is deemed to be adulterated,
regardless of whether or not the water bears a label statement of substandard quality prescri‐
bed by paragraph (c) of this section. If E. coli is present in bottled water, then the bottled water
will be deemed adulterated under section 402(a)(3) of the act [15].” Adulterated food and
beverages should not enter the food supply, and if they do, the manufacturer could face
criminal or civil penalties and mandatory recalls. Criminal penalties could be assessed under
the Park Doctrine, which places responsibility for adulterated product on company owners
and/or senior management.
The FDA’s website recall database indicates that in 2011 and 2012 there was one incidence of
a bottled water Class II recall [16]. Mountain Pure, LLC voluntarily recalled 23,000 16.9 oz.
bottles of its Mountain Pure bottled water in Clinton, AR on May 4, 2011 because of a biological
contamination. In a FDA press release, the Arkansas Department of Health said it was unlikely
that a healthy person would get sick from drinking the water, but people with a weakened
immune system might be at higher risk [17]. In 2014, in Pittsburgh there was precautionary
voluntary recall of bottled water because of a preliminary finding of E. coli in a finished
product. All confirmatory tests performed in a number of certified laboratories were negative
for both E. coli and total coliforms. These negative findings plus the high ozone concentration
used in bottled waters in Pennsylvania (plus the bottling plan in additions uses ultraviolet
light) makes this finding of E. coli without any merit.
3.3. People who have immune-compromised illnesses
Waterborne diseases can lead to serious acute, chronic and sometimes fatal health consequen‐
ces, especially for people who have compromised immune systems. Both the CDC and the
EPA advise people who have immune-compromised illnesses (such as people undergoing
chemotherapy, living with HIV/AIDS, transplant patients, children and infants, elderly and
pregnant women) to consider taking extra precautions with their drinking water [18]. An EPA
video and accompanying booklet aimed at educating health care providers about drinking
water tells providers to advise these patients to “to consider alternatives to tap water [19].”
4. Comparison of estimated incidences of public water system-borne and
bottled waterborne diseases
4.1. EPA approach to a national estimate
Research into drinking water-related incidences of acute gastrointestinal illness (AGI) is sparse
largely due to gaps in data caused by reporting uncertainties. However, the EPA has developed
an analytical approach and model for generating a national estimate of AGI illness due to
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drinking water and using this model, it is estimated that public water systems cause 16.4
million cases of AGI per year in the United States [5].
A Messner, et al. (2006) study uses AGI to measure public water system health risk because
AGI is the broadest indicator of health effects associated with most water-borne pathogens
and allows for comparison to national data on AGI incidence due to all causes. His study
focuses on public water systems because 94% of the US population lives in a community that
is served by public water systems. He acknowledges that water-borne diseases caused by non-
public water systems could be significant, but a lack of data makes it difficult to include non-
public water systems in calculating a national estimate.
In his research, Messner, et al. (2006) cites a Laval household intervention study that shows
significant differences in Highly Credible Gastrointestinal Illness (HCGI) incidences between
tap water drinkers and bottled water drinkers. “The difference in incidence between the two
groups of 0.26 cases of HCGI per person-year represents the estimated attributable risk to
drinking tap water [5].”
Meanwhile, a much broader study by Reynolds, et al. (2008) calculated all possible water-borne
infections and illnesses associated with exposure to pathogens in drinking water, not just AGI,
and concluded the estimated number of water-borne illnesses per year in the US is 19.5 million
cases [6].
5. Outbreaks associated with bottled water
The FDA testified before a United States House of Representatives Subcommittee on Oversight
and Investigations in July 2009 that the agency was aware of no major outbreaks of illness or
serious safety concerns associated with bottled water in the past decade [20]. And said:
“Because FDA's experience over the years has shown that bottled water has a good safety
record, bottled water plants generally are assigned a relatively low priority for inspection.”
At that same hearing, the Government Accountability Office (GAO) made public its report on
bottled water, which found that based on a survey of water quality or food and health
protection officials in all 50 states and the District of Columbia, there was no evidence that
bottled water caused any illnesses during the previous five years [21].
Meanwhile, the CDC attributes just five cases of AGI to bottled water in the past 10 years
[22]. (One case of AGI in 2007 caused by an unidentified agent, one case of AGI in 2004 caused
by gasoline byproducts, and three cases of AGI in 2003 caused by the chemical bromate,
unidentified chemical cleaning product, and unidentified agent.)
5.1. Outbreak comparison
The following table summarizes the estimated incidences of Public Water System-borne and
Bottled Waterborne diseases.
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Drinking Water Sources & Estimated Cases of AGI 2003 - 2012
Tap Water: 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Total
EPA 16.4m 16.4m 16.4m 16.4m 16.4m 16.4m 16.4m 16.4m 16.4m 16.4m 164m
Reynolds 19.5m 19.5m 19.5m 19.5m 19.5m 19.5m 19.5m 19.5m 19.5m 19.5m 195m
Bottled Water: 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Total
FDA 0 0 0 0 0 0 0 0 0 0 0
GAO n/a n/a n/a n/a n/a 0 0 0 0 0 0
CDC 3 1 0 0 1 0 0 0 0 0 5
Table 6. Drinking water sources & estimated cases of AGI 2003-2012
6. Distribution system and contact surface comparisons
EPA-mandated protocols are designed to effectively eliminate pathogens from public water
system drinking water, but treatment inadequacies and interruptions, as well as public
drinking water distribution system failures, have been associated with waterborne disease
outbreaks [6]. In fact, recent research indicates distribution system failures are increasingly the
cause of waterborne outbreaks [23].
The pipes that connect treatment plants to consumers’ taps span 1 billion miles in the United
States [24]. Researchers studying public health risks associated with contamination occurring
in public water supply distribution systems have found a list of probable causes including:
cross connections and backflow, intrusion caused by pressure transients, nitrification, perme‐
ation and leaching, water main repair and replacement, aging infrastructure and microbial
growth inside distribution pipes [25].
6.1. Number of outbreaks caused by public water supply distribution systems
Data from the CDC’s passive drinking water surveillance system indicates the incidence of
public water supply waterborne disease outbreaks has actually decreased since the 1980s,
presumably due to the EPA’s Surface Water Treatment Rule and the Total Coliform Rule.
However, the number of outbreaks due to public water supply distribution system issues and
failures has remained relatively consistent despite an apparent increase in the percentage of
those outbreaks (see chart below). It is also the case that if contamination occurs but only affects
a small number of people, it may not be reported and investigated as an outbreak. “Indeed, it
has been acknowledged that a fairly sizable number of cases of cryptosporidiosis could be
occurring in a large city such as New York City without detection of a possible outbreak [26].”
In a more recent update of the above data, CDC reports that in 2009-2010, there were 33
drinking water outbreaks. Of the 33 outbreaks, 25 (75.8%) occurred in community water
systems.
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6.2. Types of distribution deficiencies
Cross-connections and backflow issues pose serious public health threats. A backflow occurs
when non-potable  water  flows  directly  into  the  drinking  water  supply  through a  cross
connection,  which  occurs  when  the  system  has  low  water  pressure  or  the  non-potable
system has  backpressure  [25].  A  study that  monitored public  drinking  supply  distribu‐
tion system failures from 1981 to 2002 found that 50% of waterborne outbreaks were the
result  of  backflow [27].  A study by the University  of  Southern California  examined the
plumbing systems in 188 homes and found 9.6 percent had a direct cross connection that
presented a health risk [28].
Water main breaks are another serious problem in the United States. Each day more than 700
water mains break, 36 exposing distribution system water and pipe interiors to external
microbial and chemical contaminants, both during the break and the repair process. The EPA
estimated in 2002 that 5 percent of all waterborne outbreaks due to distribution system
deficiencies were caused by water main repairs or the installation of new pipes [29].
Issues with finished water storage (uncovered and reservoirs) is another cause of water‐
borne outbreaks as drinking water quality degrades over time and is susceptible to external
contamination from wildlife,  rain and algae [30].  Other public water supply distribution
system risks include: biofilm build-up (the growth of bacteria on distribution system pipes
and household plumbing), low-pressure intrusions [31] caused by leaks, permeation and
leaching (in fact,  7 billion gallons leak from public water supply distribution pipes each
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Figure 1. Public water supply outbreaks and percentage due to distribution systems
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day in the US [31] and the cost of water losses in 1994 was estimated $2.8 billion annual‐
ly [32]).
Biofilm build-up, by itself, has been the subject of study by the EPA, which has concluded that:
“Biofilms likely exist in all distribution systems, and are recognized as a normal part of the
distribution system”. Moreover, “…a wide range of primary and opportunistic pathogens
have demonstrated the ability to survive, if not grow, in biofilms. These pathogens are of both
fecal and non-fecal origin, and have a multitude of pathways through which they can enter
the distribution system. Some of the pathogens identified as growing or potentially surviving
in biofilms include Legionella, Mycobacterium avium complex, Pseudomonas aeruginosa,
poliovirus 1, coxsackievirus B and several species of fungi. …Once becoming established as
part of the biofilm, pathogens can be protected from disinfection [33].”
6.3. Costs to address deficiencies in us public water supply distribution systems
According to the EPA’s Drinking Water Infrastructure Needs Survey and Assessment, 2009, the
national assessment of public water system infrastructure needs shows a total twenty-year
capital improvement need of $334.8 billion, to repair or replace thousands of miles of pipe,
thousands of treatment plants, storage tanks and other assets to protect the public health [34].
The pie chart below shows the majority of need is to address deficiencies with the public water
supply distribution systems that include co-residency of leaking water pipes in the same
trenches with leaking sewage lines [35].
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Figure 2. Financial requirement by repair type
In 2002, the EPA released a Clean Water and Drinking Water Infrastructure Gap Analysis Report,
which calculated a “funding gap” of more than $500 billion dollars over the next 20 years.
(Includes $122 billion for clean water capital costs, $102 billion for drinking water capital costs,
$148 billion for clean water operation and maintenance and $161 billion for drinking water
operation and maintenance [36]).
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6.4. Water distribution
Under FDA rule (21 CFR Part 129),  bottled water is:  “required to be safe and that it  be
processed,  bottled,  held  and transported under  sanitary  conditions.  Processing practices
addressed  in  the  Current  Good  Manufacturing  Practice  (CGMP)  regulations  include
protection of the water source from contamination, sanitation at the bottling facility, quality
control to assure the bacteriological and chemical safety of the water, and sampling and
testing of source water and the final product for microbiological, chemical, and radiologi‐
cal contaminants. Bottlers are required to maintain source approval and testing records to
show to government inspectors [37].”
In addition, bottled water companies are required to conduct daily in-house total coliform
monitoring on finished product of each product type and quarterly microbial rinse/swab tests
which may be performed in-house by qualified plant personnel or by an approved laboratory
on containers (incoming as well as those immediately from the washer) and closures as
stipulated in 21 CFR Section 129.80 (f) [38]. This specific standard of sanitation for the interior
of bottles and caps is: "No more than one of the four samples may exceed more than one
bacterium per milliliter of capacity or one colony per square centimeter of surface area. All
samples shall be free of coliform organisms.” For example, not more than one of four 500 ml
containers shall exceed 500 CFUs of bacteria. None of the containers are permitted to be
positive for coliform bacteria. In comparison, there is an EPA guideline of 500 CFU/ml of
heterotrophic plate count bacteria for public drinking water in the distribution system, beyond
which the public water system must adjust disinfection levels to reduce the bacteria count.
However, distribution pipes may still be lined with biofilms that may contribute to the bacteria
load in the water.
Throughout the bottled water distribution system, each bottle is sealed and must remain sealed
until it is opened by the consumer thus eliminating risk the of contamination during the
distribution process. In addition, in the unlikely event that a problem with bottled water
occurs, the product can be easily identified and recalled using a lot number printed on the
bottled water container.
7. Conclusions
The quality of drinking water in the United States is extensively monitored and regulated by
federal, state and local agencies, yet a close examination of both public system drinking wa‐
ter and bottled water processing and distribution procedures reveals striking differences
that could explain why consumers have safety concerns regarding tap water. This paper has
shown that on a gallon for gallon basis bottled water is tested more often than tap water. It
is also the case that water quality breach notification differences means tap water drinkers
would consume potentially hazardous drinking water before they are notified. Bottled wa‐
ter is tested before the water leaves the plant, and is withheld or withdrawn if the water
does not meet FDA water quality standards.
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A comparison of waterborne illness outbreaks reveals overwhelming evidence that the mi‐
crobial health risks associated with drinking tap water are far greater than that of bottled
water, with 195 million illnesses in the past 10 years for tap water compared to fewer than a
dozen for bottled water.
In examining public water supply distribution systems, this paper highlights how deficien‐
cies in these systems are key factors and causes of compromised tap water quality.
Overall, water is a precious resource. It has many uses for which there is no substitute and
is  therefore  needed in  many different  ways  for  our  survival  and endurance.  Thus,  safe
drinking water holds great value and to maintain its safety the public needs to stay educated
and  aware.  Our  government  regulations  are  working  to  protect  and  produce  our  safe
drinking water supply, but more needs to be done. And an informed consumer can help
drive policies that will meet the needs of the American people—and ensure a safe drinking
water supply.
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